“No ink on tumor” means your surgeon removed the entire visible tumor with a clean border of healthy tissue around it. It’s the standard definition of a negative, or clear, surgical margin in breast cancer, and it’s the result you want to see on your pathology report. In practical terms, it means no cancer cells were found at the very edge of the tissue that was removed.
How Pathologists Check Your Margins
After a surgeon removes a tumor, the tissue specimen goes to a pathology lab. There, a pathologist coats the outer surface of the removed tissue with colored ink, sometimes using multiple colors to mark different sides. The ink dries, soaks into the outer edge, and stays visible even under a microscope. The specimen is then sliced into thin sections so the pathologist can examine the boundary between the tumor and the inked edge.
If cancer cells are touching the ink, that’s called a positive margin, or “ink on tumor.” It means the cut was made too close to the cancer, and some tumor cells may still be in your body at that location. If there’s a visible gap of normal tissue between the cancer cells and the ink line, that’s a negative margin: “no ink on tumor.” The tumor was fully contained within the removed tissue.
Why This Phrase Matters in Breast Cancer
The phrase comes up most often after a lumpectomy (breast-conserving surgery). In 2014, the Society of Surgical Oncology and the American Society for Radiation Oncology published a joint consensus guideline establishing “no ink on tumor” as the standard margin definition for invasive breast cancer treated with lumpectomy and radiation. The guideline was based in part on the long-running NSABP B-06 trial, which used “no ink on tumor” as its margin definition and reported a 5% rate of cancer returning in the same breast after 12 years of follow-up when patients also received systemic therapy.
Before this consensus, surgeons varied widely in how much clear tissue they wanted around the tumor. Some aimed for 1 mm, others for 2 mm or even 5 mm, and many patients were sent back for a second surgery to widen margins that were already negative. The expert panel concluded that wider margins beyond “no ink on tumor” do not significantly lower the risk of the cancer coming back. Getting a bigger border of clear tissue sounds intuitively better, but the data didn’t support that instinct for invasive breast cancer treated with radiation.
Positive vs. Close vs. Negative Margins
Pathology reports typically describe margins in one of three ways:
- Positive margin (ink on tumor): Cancer cells are right at the inked edge. This carries the highest risk of local recurrence, roughly 25% in one study comparing outcomes across margin types.
- Close margin: Cancer cells are near the ink but not touching it, usually within 1 to 2 mm. Recurrence rates in this category fall around 10%.
- Negative margin (no ink on tumor): A clear gap exists between cancer cells and the ink. Recurrence rates drop to about 5%.
These numbers illustrate why the distinction matters so much. A positive margin is associated with a fivefold higher recurrence risk compared to a negative one.
What Happens If Your Margins Are Positive
When ink is found on tumor, guidelines recommend a second surgery, either a re-excision (going back in to remove more tissue from that area) or, in some cases, a mastectomy. The goal is to achieve clear margins before moving on to radiation or other treatments.
Not every positive margin carries the same level of concern. Patients with a single positive margin, no lymphovascular invasion (where cancer cells have entered nearby blood or lymph vessels), and a single tumor focus tend to have a much lower risk of residual cancer being left behind. In contrast, having two or more positive margins nearly triples the odds of residual disease, and lymphovascular invasion increases those odds roughly ninefold. Your surgical team weighs these factors when deciding the best next step.
The DCIS Exception
If your pathology report involves ductal carcinoma in situ (DCIS), a non-invasive form of breast cancer, the margin standard is slightly different. For DCIS, the recommended optimal margin is 2 mm or greater, not simply “no ink on tumor.” This wider requirement exists because DCIS can grow in scattered patterns through the milk ducts, making it harder to ensure complete removal with only a razor-thin clear border.
For DCIS patients who skip radiation, wider margins become even more important. Progressive increases in margin width are associated with progressively lower recurrence risk, with margins greater than 10 mm reducing recurrence risk by as much as 69% compared to close or positive margins. For those who do receive radiation, the benefit of going beyond 2 mm shrinks considerably, because radiation helps mop up any microscopic cells near the edges.
How Margins Relate to Radiation
Lumpectomy for invasive breast cancer is almost always followed by whole-breast radiation. Radiation targets any cancer cells that might remain in the breast tissue, and it works in partnership with the surgical margin. When margins are clear, radiation provides an additional safety net. When margins are positive or close, radiation carries more of the burden, and the absolute benefit of radiation is larger.
This relationship explains why “no ink on tumor” is considered sufficient for invasive cancer: radiation handles the microscopic uncertainty that a wider margin would otherwise address. It also explains why DCIS patients who forgo radiation are held to a stricter 2 mm standard. Without radiation as a backup, the margin itself needs to do more of the work.
What “No Ink on Tumor” Means for You
If your pathology report says “no ink on tumor” or “negative margins,” it means the surgery accomplished its primary goal. The tumor was removed with a surrounding buffer of healthy tissue, and no cancer cells were found at the cut edge. For invasive breast cancer followed by radiation, this result meets the national standard of care and does not require further surgery to widen the margins.
Your report may also mention the exact distance between the nearest cancer cells and the ink, measured in millimeters. For invasive cancer, any distance greater than zero qualifies as negative. For DCIS, you want to see 2 mm or more. If your margin measurement falls in a gray zone, your care team will factor in your specific tumor characteristics, whether radiation is planned, and other treatment details to determine whether additional surgery would meaningfully reduce your risk.